AKUMSPharmaceuticals
Akums Drugs & Pharmaceuticals Ltd — PE Ratio & Valuation Analysis
₹466.10
-3.81%
Current P/E21.76xPrice to earnings
Industry P/E31.77xSector average
4Y Avg P/E20.1x8.3% above avg
✅
31.5% Discount to Industry
AKUMS P/E 21.76x vs sector avg 31.77x
📊
Historical PE Ratio
| Year | EPS (₹) | Year-end Price | PE Ratio |
|---|---|---|---|
| 2025 | ₹22.60 | ₹453 | 20.1x |
PE = Year-end closing price ÷ Diluted EPS. Source: NSE/BSE filings.
💡
Understanding Akums Drugs & Pharmaceuticals Ltd Valuation
Akums Drugs & Pharmaceuticals Ltd (AKUMS) currently trades at 21.76x earnings. The Pharmaceuticals sector average PE is 31.77x. AKUMS is trading at a discount to peers — may indicate relative value. Historically, AKUMS has traded at an average PE of 20.1x — it is currently above that level. Always evaluate PE alongside earnings growth (PEG ratio), return on equity, debt levels and business quality. A lower PE isn't always better. Educational data only — not investment advice.
ROE
17.19%
Dividend Yield
0.00%
More on Akums Drugs & Pharmaceuticals Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.